White label ELPA - ClinicalTrials.eu

Study on Lidocaine and Sodium Chloride for Patients Undergoing Liver Tumor Surgery

Not recruiting

4 1 1
Investigated Drugs:
- Lidocaine
- Sodium Chloride
Long-Term Safety Study of Dupilumab for Children and Teens with Atopic Dermatitis

Not recruiting

3 1 1 1
Investigated Diseases:
- Dermatitis atopic
Investigated Drugs:
- Dupilumab
Study on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma

Not recruiting

2 1 1
Investigated Diseases:
- Malignant melanoma
Investigated Drugs:
- Cemiplimab
- Fianlimab
+2
Study of Avalotcagene Ontaparvovec for Patients Aged 12 and Older with Late-onset Ornithine Transcarbamylase Deficiency

Not recruiting

3 1 1
Investigated Diseases:
- Ornithine transcarbamoylase deficiency
Investigated Drugs:
Study of GEN3014 and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma and Other Blood Cancers

Not recruiting

2 1 1 1
Investigated Drugs:
- Daratumumab
+1
Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Not recruiting

2 1 1
Investigated Diseases:
- Systemic scleroderma
Investigated Drugs:
- Fipaxalparant
+3
Study on Levothyroxine and Sildenafil for Improving Erectile Function in Patients with Subclinical Hypothyroidism and Erectile Dysfunction

Not recruiting

3 1 1 1
Investigated Diseases:
- Hypothyroidism
Investigated Drugs:
- Sildenafil Citrate
- Levothyroxine
Long-term Safety Study of INZ-701 for Patients with ENPP1 and ABCC6 Deficiencies, Including Pseudoxanthoma Elasticum and Generalized Arterial Calcification of Infancy

Not recruiting

2 1 1
Investigated Drugs:
- Recombinant Human Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Fused To The Fc Fragment Of Igg1
Study on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

Not recruiting

3 1 1 1
Investigated Diseases:
- EGFR gene mutation
- Non-small cell lung cancer
Investigated Drugs:
+12
Study Comparing Bomedemstat and Hydroxycarbamide for Patients with Essential Thrombocythemia

Not recruiting

3 1 1
Investigated Diseases:
- Essential thrombocythaemia
Investigated Drugs:
- Bomedemstat
- Hydroxycarbamide
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies